Rockwell Medical Technologies (RMTI) Prices ~3.2M Share Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/13/2026
- Nasdaq falls ahead of earnings, economic data while oil rallies
- Oil prices rise on Saudi Arabia attacks, overshadowing Trump's diesel deal
- Will surging equity supply derail the U.S. bull market? Goldman Sachs weighs in
- Broadcom CEO says many AI investors are gamblers
- "Not buying Chipotle": Starbucks squashes blockbuster acquisition speculation
- Bausch + Lomb names Appio interim CEO as Saunders departs
- Cerebras Systems hits new 52-week low on unlock concerns
- Getty Images to go private via prepackaged Chapter 11 restructuring
- Kroger (KR) To Cut Corporate Workforce By About 3,000 Over 3 Years - Bloomberg
- Sysco calls on Teamsters to end LA strike after economic deal reached
Rockwell Medical Announces Pricing of $7.5 Million Public Offering of Common Stock
February 4, 2020 9:20 AM ESTWIXOM, Mich., Feb. 04, 2020 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI) (Rockwell Medical or the Company), a biopharmaceutical company dedicated to transforming anemia management and improving outcomes for patients around the world, today announced the pricing of its underwritten public offering of 3,191,489 shares of its common stock for gross proceeds of approximately $7.5 million, before deducting the underwriting discounts and commissions and other estimated offering expenses payable by Rockwell Medical. The offering is expected to close on or about February 6, 2020, subject to customary closing conditions. In addition, Rockwell Medical has granted the underwriter a 30-day option to... More



